310 results
8-K
EX-10.4
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.3
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.2
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
16 Nov 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
pn0sqr2m6n5o4ue4jubx
28 Jul 23
Departure of Directors or Certain Officers
5:10pm
8-K
EX-10.1
d6zyzgjb
6 Jul 23
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
4:39pm
8-K
EX-10.1
51qh1kud0m0o8
16 Jun 23
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
5:24pm
8-K
EX-10.1
nz482rewgofc02y1
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.1
hw6 r5juu
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.2
fxki4z 9co
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.3
xnb jeiqq
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.1
kp4pa8 95nmrjtvjq337
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.2
8g0wevi a6rlukigvt
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.4
l5szbns0sewt
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.1
6p12 o9lax04h
13 Apr 23
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
5:24pm
8-K
EX-10.1
umjpme4rj 1lpxkcw
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
8-K
EX-10.2
rr1yem 5k
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
S-8
EX-10.1
gjplslp2
22 Dec 22
Registration of securities for employees
4:19pm
8-K
EX-10.1
2nnk0nmuu 3wf
12 Apr 22
Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American
4:11pm